amylin glp-1 dual agonist Weight loss medicine is entering a new phase. CagriSema is one of the most talked-about emerging therapies right nowโand for good reason. This dual- approach combines: ๐งฌ Semaglutide (GLP-1) ๐งฌ Cagrilintide (amylin The effect of amycretin, a
Description
Research suggests it may increase endogenous GLP-1 secretion from intestinal L-cells, providing a mild GLP-1 boosting effect that complements rather than replaces exogenous GLP-1 therapy

Nat Med (2022) 28:5918

Exercise regularly: Physical activity boosts GLP-1 secretion and insulin sensitivity

JAMA Ophthalmol

Together, these findings suggest a rapid but short-lived shift in switching and prescribing patterns following the formulary change

The rapidly growing body of evidence shows that bariatric/metabolic surgery holds advantages in magnitude, durability, cost, and health outcomes for many patients
